The old man and the new pretenders: TAVI, mitral and tricuspid valve interventions

Dr Paul Williams is a Consultant Interventional Cardiologist at James Cook University Hospital, performing both structural and coronary procedures, including TAVI and MitraClip.

Dr Williams has a major interest in evolving TAVI into a minimally invasive procedure with a very short length of hospital stay. His unit was the first in the UK to introduce the percutaneous axillary approach as an alternative access for TAVI and it has an established daycase TAVI programme for selected patients. He has proctored both nationally and internationally for TAVI implantation.

Professor Andreas Baumbach is Chair of Device Innovation and Consultant Interventional Cardiologist at the Barts Heart Centre and Queen Mary University of London.

Professor Baumbach is active in coronary and structural intervention, and has published extensively in the field of interventional research covering preclinical, first in man, pivotal and post market studies. He has an interest in device innovation and regulatory pathways.

Professor Baumbach has a strong commitment to training and education. He is on the board of directors of the largest interventional congress EuroPCR and PCR London Valves. He is the Immediate Past President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Dr Ozkor, MBBS, BSc, FRCP, MD, qualified at Imperial College School of Medicine, in 1997.

In 2005, Dr Ozkor took a three year sabbatical to complete his MD at Emory University in Atlanta, USA. He was awarded a British Cardiovascular Society Research Fellowship to undertake a National Institute of Health funded translational research study, focusing on vascular and endothelial function.

Dr Ozkor was appointed as Consultant Cardiologist to The Heart Hospital, University College Hospitals and North Middlesex University Hospital, in November 2010 and since the merger in 2015 now works at Barts Heart Centre.

Dr Ozkor is a Consultant Cardiologist is Cath Lab Director at Barts Heart Centre and Clinical Director at NMUH. He specialises in minimally invasive interventional procedures for heart valves, TAVI and complex coronary treatments. He also has a keen interest in patient management and driving patient safety.

Dr Michael Mullen is a Consultant Cardiologist and the Clinical Lead for Structural Heart Intervention at Barts Heart Centre in London. He is internationally recognised for his expertise in the transcatheter treatment of structural heart disease, with nearly 20 years of experience in this field. He has played a key role in the development of new technologies for the treatment of congenital and acquired structural heart conditions and their introduction into the UK, including transcatheter aortic valve implantation (TAVI), MitraClip, Cardioband and suture closure of patent foramen ovale. Dr Mullen has a broad research portfolio, leading and participating in numerous clinical trials and is frequently invited to give lectures and live demonstrations at national and international conferences.